Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Amortization of Deferred Charges: 2012-2013

Historic Amortization of Deferred Charges for CorMedix (CRMD) over the last 1 years, with Mar 2013 value amounting to $81,396.

  • CorMedix's Amortization of Deferred Charges was N/A to $81,396 in Q1 2013 from the same period last year, while for Mar 2013 it was $6.2 million, marking a year-over-year change of. This contributed to the annual value of $142,000 for FY2012, which is N/A change from last year.
  • CorMedix's Amortization of Deferred Charges amounted to $81,396 in Q1 2013, which was up 12.70% from $72,222 recorded in Q4 2012.
  • In the past 5 years, CorMedix's Amortization of Deferred Charges ranged from a high of $3.0 million in Q2 2012 and a low of $72,222 during Q4 2012.
  • In the last 2 years, CorMedix's Amortization of Deferred Charges had a median value of $1.5 million in 2012 and averaged $1.5 million.